Dimerix Limited (SBMJF)
OTCMKTS · Delayed Price · Currency is USD
0.3500
+0.1000 (40.00%)
At close: Jun 4, 2025
Dimerix Market Cap
Dimerix has a market cap or net worth of $215.07 million as of February 12, 2026. Its market cap has increased by 42.23% in one year.
Market Cap
215.07M
Enterprise Value
166.70M
Revenue
3.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.35
Market Cap Chart
Since July 6, 2015, Dimerix's market cap has increased from 9.95M to 215.07M, an increase of 2,062.05%. That is a compound annual growth rate of 33.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 215.07M | -2.36% |
| Dec 31, 2025 | 220.26M | 87.65% |
| Dec 31, 2024 | 117.38M | 97.14% |
| Dec 29, 2023 | 59.54M | 88.29% |
| Dec 30, 2022 | 31.62M | -44.68% |
| Dec 31, 2021 | 57.16M | 59.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 411.40M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 141.56M |
| HST Global | 139.70M |
| BioStem Technologies | 92.40M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |